IDEXX Laboratories

IDEXX Laboratories EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of IDEXX Laboratories (IDXX) as of Nov 17, 2026 is 36.95. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 44.54 — a change of -17.04% (lower).

EV/EBIT

36.95

YoY

-17.04%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of IDEXX Laboratories is 2025 36.95 . EV/EBIT (Enterprise Value to EBIT) of IDEXX Laboratories was 2024 44.54 . It decreases by -17.04% lower compared to the previous year.

The IDEXX Laboratories EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
90.90 USD
Jan 1, 2020
72.36 USD
Jan 1, 2021
53.92 USD
Jan 1, 2022
55.91 USD
Jan 1, 2023
45.81 USD
Jan 1, 2024
44.54 USD
Jan 1, 2025
36.95 USD
Jan 1, 2026 (e)
37.13 USD
The IDEXX Laboratories EV/EBIT history
YEAREV/EBITYoY
est37.13+0.48%
36.95-17.04%
44.54-2.77%
45.81-18.08%
55.91+3.70%
53.92-25.48%
72.36-20.40%
90.90-11.13%
102.28-15.94%
121.67-15.20%
143.49-14.37%
167.56-13.22%
193.10+818.20%
21.03+6.64%
19.72+9.62%
17.99-7.79%
19.51+10.66%
17.63+42.41%
12.38-52.77%
26.21+35.80%
19.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IDEXX Laboratories Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides IDEXX Laboratories's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates IDEXX Laboratories's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots IDEXX Laboratories's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if IDEXX Laboratories grows earnings faster than its peers.

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IDEXX Laboratories stock

EV/EBIT (Enterprise Value to EBIT) of IDEXX Laboratories is 36.95 in 2025.

EV/EBIT (Enterprise Value to EBIT) of IDEXX Laboratories changed from 44.54 to 36.95, representing a -17.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s IDEXX Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — IDEXX Laboratories

All Key Metrics — IDEXX Laboratories